Teligent Pharma, Inc. recalls Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena,…
- Recall date
- October 12, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0280-2022
- FDA classification
- Class I
- Brand / firm
- Teligent Pharma, Inc.
- Sold / distributed
- Nationwide within the United States
Why it was recalled
Superpotent Drug
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50
Get recall alerts
Free email alert whenever Teligent Pharma, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Teligent Pharma, Inc.